USING DEXMEDETOMIDINE AS THE MAIN AGENT FOR ANESTHETIC MANAGEMENT DURING RADIOSURGERY IN A CHILD
https://doi.org/10.21292/2078-5658-2018-15-6-69-73
Abstract
This clinical case demonstrates specific features of anesthetic management during radiosurgery in pediatric patients considering the limited access to them during continuous manipulations with pharmacological sedation. Considering the age of the child, dexmedetomidine, the drug from the group of agonists of α2-adrenergic receptors, was used as the main agent. It was used since it could be administred by the noninvasive way for premedication and intravenously in a form of infusion to provide the necessary depth of sedation with preservation of spontaneous breathing and minimization of uncontrolled motions of the patient.
About the Authors
A. M. Аrefiev
N. N. Burdenko National Scientific and Practical Center for Neurosurgery
Russian Federation
Russian Federation
Aleksandr M. Arefiev - Post-Graduate Student, Anesthesiologist of Anesthesiology and Intensive Care Department
Phone: +7 (499) 972‒86‒68
16, 4th Tverskaya-Yamskaya St., Moscow, 125047
A. Yu. Lubnin
N. N. Burdenko National Scientific and Practical Center for Neurosurgery
Russian Federation
Russian Federation
Andrey Yu. Lubnin - Doctor of Medical Sciences, Professor, Head of Anesthesiology and Intensive Care Department
Phone: +7 (499) 972‒86‒68
16, 4th Tverskaya-Yamskaya St., Moscow, 125047
A. S. Kulikov
N. N. Burdenko National Scientific and Practical Center for Neurosurgery
Russian Federation
Russian Federation
Aleksandr S. Kulikov - Candidate of Medical Sciences, Senior Researcher of Anesthesiology and Intensive Care Department
Phone: +7 (499) 972‒86‒68
16, 4th Tverskaya-Yamskaya St., Moscow, 125047
References
1. Аrefiev А.M., Kulikov А.S., Lubnin А.Yu. Dexmedetomidine in neuroanesthesiology. Anesteziologiya i Reanimatologiya, 2017, vol. 62, pp. 213-219. doi: 10.18821/0201-7563-2017-62-3-213-219. (In Russ.)
2. Golanov А.V., Kulikov А.S., Sorokin V.S. et al. Stereotaksicheskoe obluchenie patologii TSNS na apparate KiberNozh.[Stereotaxic radiation of CNS pathology using CyberKnife]. Izdatelstvo IP T.А. Аlekseeva Publ., 2017, pp. 559-574.
3. Kulikov А.S., Sorokin V.S., Lubnin А.Yu. Peroral premedication with midazolam and ketamine in children with neurosurgical disorders. Anesteziologiya i Reanimatologiya, 2010, vol. 1, pp. 6-10. (In Russ.)
4. Shmigelskiy А.V., Polupan А.А., Kulikov А.S. et al. Peri-operative development of critical bradyarrhythmia during the use of dexmedetomidine. Clinical case. Regionar. Anestesia i Lecheniye Ostroy Boli,2015, vol. 9, no. 4, pp. 22-26. (In Russ.)
5. Amber T., Miller J.L., Couloures K. Non-intravenous sedatives and analgesics for procedural sedation for imaging procedures in pediatric patients. J. Pediatr. Pharmacol. Ther.,2015, vol. 20, no. 6, pp. 418-430.
6. Behrle N., Birisci E., Anderson J. et al. Intranasal dexmedetomidine as a sedative for pediatric procedural sedation.J. Pediatr. Pharmacol. Ther., 2017, vol. 22, no. 1, pp. 4-8.
7. Fahy C.J., Okumura M. Sedation for paediatric stereotactic radiosurgery: the dexmedetomidine experience. Anaesth. Int. Care, vol. 32, no. 6, pp. 809-811.
8. Green S.M., Hummel C.B., Wittlake W.A. et al. What is the optimal dose of intramuscular ketamine for pediatric sedation?Acad. Emerg. Med.,1999, vol. 6, no. 1, pp. 21-26.
9. Guenther E., Pribble C.G. et al. Propofol sedation by emergency physicians for elective pediatric outpatient procedures. Ann. Emerg. Med., 2003, vol. 42, no. 6, pp. 783-791.
10. Gupta A., Dalvi N.P., Tendolkar B.A. Comparison between intranasal dexmedetomidine and intranasal midazolam as premedication for brain magnetic resonance imaging in pediatric patients: A prospective randomized double blind trial. J. Anaesthesiol. Clin. Pharmacol., 2017, vol. 33, no. 2, pp. 236-240.
11. Kamata K., Hayashi M., Muragaki Y. et al. How to control propofol infusion in pediatric patients undergoing gamma knife radiosurgery. Acta Neurochir., Suppl.2013, vol. 116, pp. 147-150.
12. Li B.L., Zhang N., Huang J.X. et al. A comparison of intranasal dexmedetomidine for sedation in children administered either by atomiser or by drops. Anaesthesia, 2016, vol. 71, pp. 522-528.
13. Mahmoud M., Mason K.P. Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations. Br. J. Anaesth., 2015, vol. 115, no. 2, pp. 171-182.
14. Mason K.P., Michna E., DiNardo J.A. et al. Evolution of a protocol for ketamine-induced sedation as an alternative to general anesthesia for interventional radiologic procedures in pediatric patients. Radiology, 2002, vol. 225, no. 2, pp. 457-465.
15. Miller J.W., Divanovic A.A., Hossain M.M. et al. Mahmoud MADosing and efficacy of intranasal dexmedetomidine sedation for pediatric transthoracic echocardiography: a retrospective study. Can. J. Anaesth., 2016, vol. 63, no. 7, pp. 834-841.
16. Olgun G., Ali M.H. Use of intranasal dexmedetomidine as a solo sedative for MRI of infants. Hosp. Pediatr., 2018, vol. 23. pii: hpeds.2017-0120.
17. Yuen V.M., Hui T.W., Irwin M.G. et al. Optimal timing for the administration of intranasal dexmedetomidine for premedication in children. Anaesthesia, 2010, vol. 65, no. 9, pp. 922-929.
Review
For citations:
Аrefiev A.M., Lubnin A.Yu., Kulikov A.S. USING DEXMEDETOMIDINE AS THE MAIN AGENT FOR ANESTHETIC MANAGEMENT DURING RADIOSURGERY IN A CHILD. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2018;15(6):69-73. (In Russ.) https://doi.org/10.21292/2078-5658-2018-15-6-69-73
Email this article 